dr. gradishar on selecting agents for her2 breast cancer
Published 6 years ago • 130 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
1:44
dr. gradishar discusses the treatment of her2 breast cancer
-
0:50
dr. gradishar discusses dual her2-targeting in breast cancer
-
2:06
dr. gradishar on personalized treatment in breast cancer
-
0:52
dr. gradishar on the role of neratinib in the treatment of her2 breast cancer
-
2:04
dr. gradishar on using genetic testing to identify actionable results in breast cancer
-
2:57
dr. gradishar comments on the treatment of early stage breast cancer with endocrine therapy
-
1:37
dr. bhave on promising anti-her2 agents in her2 breast cancer
-
1:07
dr. tripathy on neoadjuvant agents for her2 breast cancer
-
2:09
dr. william gradishar on updates in nccn breast cancer guidelines
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
1:13
dr. hamilton on the efficacy of trastuzumab deruxtecan in her2-low breast cancer
-
2:01
dr. hurvitz on her2-targeted therapies in breast cancer
-
2:03
dr. hurvitz on novel agents in her2-positive breast cancer
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
1:29
dr. geyer on impact of targeted agents in her2 breast cancer
-
0:45
dr. davis on immunotherapy in her2-positive gastric/gej cancer
-
0:57
dr. mittendorf on the impact of pertuzumab in her2 breast cancer
-
0:52
dr. o'regan on impact of targeted agents in her2 breast cancer
-
2:30
dr. pegram on neoadjuvant treatments for her2-postive breast cancer